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Background: Since 2009, HIV mass screening of the 15–70-year-old general population in low-risk situations has
been recommended in France. This, not yet implemented, untargeted screening would be cost-effective with a
positive impact on public health. No previous studies had interrogated primary care patients about it. This study
aimed at exploring perceptions of patients attending general practitioner’s on HIV mass screening and at
identifying barriers to its implementation.
Methods: We conducted a qualitative study through semi-structured individual interviews. Participants were
recruited according to age, gender and location of their physician’s practice. Data analysis was based on
triangulation by two researchers.
Results: Twenty-four interviews were necessary to obtain data saturation. HIV transmission was mostly associated
with sexual intercourse; main barriers stemming from the screening were related to sexuality, often seen as
questioning spouse’s faithfulness. It could interfere with religiosity, implying an upsetting perception of sexuality
among the elderly. Patients’ beliefs and perceptions regarding HIV/AIDS, the fear to be screened and difficulties to
talk about sexuality were other barriers.
Conclusion: To our knowledge, no studies had previously interrogated primary care patients about barriers to HIV
mass screening in France. Although relevance of this untargeted screening is debated in France, our results could
be helpful to a better understanding of patients’ attitudes toward this and to an outstanding contribution to
reduce the number of new cases of HIV contamination.Background
About 33 million people are infected with the human
immunodeficiency virus (HIV) worldwide [1]. In France,
approximately 150,000 people are HIV-positive, among
them 50,000 being unaware of it [2-4]. Between 6,000
and 8,000 new HIV-positive diagnoses are made each
year, a third of these at an AIDS stage. In 2004,
according to the French Institute for Public Health
Surveillance (Institut de veille sanitaire, InVS), 47% of
adults were not aware of being HIV-positive at the time
of the diagnosis of AIDS, 46% of them were heterosexuals
born in France [5]. In 2009, 62% of cases of infection
resulted from heterosexual contact, and over 50% of urban
cases occurred in Île-de-France [6].* Correspondence: olivier.saint-lary@uvsq.fr
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distribution, and reproduction in any mediumSince 2009, mass screening of the low-risk 15–70-
year-old general population has been recommended.
This screening would be beneficial in terms of public
health and cost-effective [7] although a recent French
study questioned its utility [8]. Early diagnosis of HIV
infection would have an individual and collective positive
impact [9-14].
This untargeted screening in general population is not
currently implemented in common practice and the
2009 recommendation has not made any change as the
number of newly diagnosed HIV-positive cases has been
stable since 2008 [15].
The use of qualitative methods is becoming more
common in medical research in general and about HIV
in particular [16,17] but few studies focused on the
“patient” viewpoint [18]. The question of mass screening
in general population has been mainly studied from a
medico-economic perspective and in terms of public
health impact [14,19-25]. Some qualitative studies haveMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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acceptance of HIV testing in primary care clinic in San
Francisco [26] or querying only seropositive for HIV
[27]. In the United Kingdom one study queried the feasi-
bility of a rapid test in primary care [28]. But to our
knowledge, no study has directly interviewed primary
care patients in France about the opportunity of HIV
mass screening.
Our study aimed at exploring perceptions of patients
attending general practitioner’s on HIV mass screening
and at identifying barriers to its implementation.
Method
Study type
A qualitative study through semi-structured individual
interviews was performed [29,30]. Individual interviews
were preferred to focus groups because the HIV theme
is related to the private sphere and to sexuality and
could compromise the quality of group exchanges [31].
We adhered to the RATS guidelines.
Recruitment of participants
General practitioners exercising in Yvelines (one of the
eight departments of the Île-de-France region, France)
and internship supervisor at the Faculty of Health
Sciences of Paris–Ile-de-France–Ouest invited their
patients to take part in the study. The patients were
recruited according to their age and gender, as well as
the location of their physician’s practice, in order to
obtain a great diversity. The participants should be aged
18 to 70 but we deliberately did not include minor pa-
tients (<18 year old) due to ethical issues and interview
feasibility (a written agreement of both parents would
have been required). A HIV-positive status already
known by their attending physicians was an exclusion
criterion.
The number of interviews was not set in advance. The
objective was to achieve data saturation, defined in our
study as the lack of any new theme raised during three
consecutive interviews. Oral consent was sought system-
atically before each interview both by their attending GP
and by the interviewer. The participants were advised
that the interview could be interrupted at any time.
Management of the interviews
The interviews were conducted by an intern of general
medicine and took place at the practice of three general
practitioners who were internship supervisors at the fac-
ulty of health sciences of Paris–Île-de-France–Ouest. In-
terviews took place in a quiet separate room, in order to
respect patients’ privacy. An interview guide that was
intentionally undetailed in order to facilitate expression
(Appendix 1) was used to guide the interviews. Ques-
tions were deliberately open to limit potential bias linkedto the researchers’ opinions on the subject [32]. Comple-
tion questions were provided in order to get more
detailed answers but they were intentionally kept at a
minimum. The participants were not incentivized.
Data analysis
Several steps were followed to realize an inductive
analysis of thematic content, with category construction
based on analysis of the participants’ opinions. The
inductive approach is a systematic procedure to analyze
qualitative data in which the identified themes are a
cluster of meaning like connected categories. Its primary
purpose is to allow research findings to rise from the
frequent, dominant or significant themes inherent in
raw data. All the interviews were led by a resident in
general practice, lasting from 3 to 15 minutes. Each indi-
vidual interview was audio-recorded using two digital
voice recorders, then transcribed into a computer file
(Word). The recordings were destroyed after analysis
out of respect for medical confidentiality and the private
nature of the recorded data. The verbatim transcriptions
were read several times, choosing units of meaning,
identifying general themes, categorizing and classifying.
The investigators’ triangulation involved two different
researchers in the analysis process. The same method
was used by each of them to analyze the data. Each
evaluator’s findings were compared in order to optimize
the data conformity.
Ethical statement
The study has been reviewed by an ethics committee,
the “Comité de Protection des Personnes Île-de-France
XI” and the committee conclusions were that an ethical
approval was not required under French law (law of the
August 9, 2004).
Results
In total, 24 interviews were needed to achieve data satur-
ation. The participants (41-years-old in average) included
11 men and 13 women (Table 1).
Barriers to the HIV mass screening related to sexuality
Most of interviewed patients associated HIV transmis-
sion with sexual relations, so they considered that the
screening inevitably questioned their spouse’s fidelity:
“we cannot always have suspicions and get screened every
6 months” (female patient no. 2). Marriage was seen by
some as a guarantee of fidelity and therefore made the
screening unnecessary: “All married couples, if they’re
faithful, I don’t think they need to be screened” (male
patient no. 9). Similarly, religion (Catholicism in our
study) was supposed to protect patients from high-risk
relations: “young, very devout Catholics […] would only
ever have sexual relations with their wife or husband […],
Table 1 Characteristics of participants (n = 24)
Patient Age Gender Location of physician’s practice
Patient 1 44 Female Marly le Roi
Patient 2 37 Female Marly le Roi
Patient 3 68 Male Marly le Roi
Patient 4 62 Male Marly le Roi
Patient 5 70 Male Marly le Roi
Patient 6 47 Female Marly le Roi
Patient 7 39 Male Marly le Roi
Patient 8 25 Male Versailles
Patient 9 34 Male Versailles
Patient 10 20 Male Versailles
Patient 11 49 Female Versailles
Patient 12 33 Male Versailles
Patient 13 53 Female Versailles
Patient 14 19 Female Versailles
Patient 15 51 Male Rambouillet
Patient 16 20 Female Rambouillet
Patient 17 53 Female Rambouillet
Patient 18 54 Female Rambouillet
Patient 19 31 Female Rambouillet
Patient 20 69 Female Rambouillet
Patient 21 40 Male Rambouillet
Patient 22 40 Female Rambouillet
Patient 23 21 Male Versailles
Patient 24 18 Female Versailles
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no. 24). Moreover, participants thought that sexuality was
virtually inexistent among the elderly and questioned the
need of screening for them: “For old people, I think it’s not
necessary […] I don’t think 70-year-old people have a sex
life” (female patient no. 2).
Criticism of public policies
Several patients, particularly those older than 40, consid-
ered the cost of public health to be another barrier. “Why
incur those costs for the community?” (female patient no.
6). Criticisms concerned public health policies and com-
munication aimed at the general public: anticipated bene-
fits of screening and lack of information about screening
methods. Information overload was also criticized as it
could lead to information saturation and induce distrust
in prevention campaigns: “Too much info kills the info. […]
You get overloaded and you want to think about something
else” (female patient no. 13).
HIV beliefs and perceptions
Fear of HIV-associated illness was considerable for
some. Knowledge about this subject, even vague, onlyexacerbates this apprehension: “some people wouldn’t
dare to participate, because they’re afraid […]. This
disease scares people” (female patient no. 16). The fear
of test result can add to that of the disease: “They’re
afraid to go find out the result” (male patient no. 9).
The lack of screening of ‘others’ was viewed critically:
“I think they don’t think they have any chance of catching
it, they feel well and have no symptoms, they don’t think
they’re carriers” (female patient 18). However, a concur-
rent feeling of being personally protected could exist:
“Not everyone is in danger of catching that disease […]
From that point of view, I’m completely safe” (male pa-
tient no. 4). Living in France could also provide a feeling
of protection: “It depends on the country. I don’t think
France is much affected” (male patient no. 8).
Patients also reported the embarrassment that some-
times prevents them from discussing about HIV, even
with their physician: “To be honest I thought of asking
him, but I don’t really dare ask the doctor” (female
patient no. 19). “It’s a taboo subject […] it’s like it’s some-
thing you shouldn’t talk about” (male patient no. 23).
Discussion
Our results provide a better insight into barriers to the
HIV mass screening from the patients point of view and
clarify their beliefs and perceptions.
The only mode of HIV transmission clearly identified
by the interviewed patients was sexual contact. HIV was
associated with unprotected sexual intercourses and infi-
delity, and patients were often unaware of the other
modes of transmission, such as contact with blood or
blood product (e.g. blood transfusion, intravenous drugs
use, tattooing, piercings) and mother-to-child [33,34].
The fact that HIV transmission means sexual intercourse
in patients’ mind, the HIV mass screening was suscep-
tible to question fidelity within couple, to acknowledge
the sexuality of the elderly and to raise discrepancies
with religion. These factors could constitute barriers to
the implementation of the screening.
The HIV mass screening could be perceived as
questioning the fidelity between spouses and thus to be
difficult to accept. How could patients agree to be
screened for a disease against which the presumed fi-
delity of their spouse is supposed to protect them? The
theme of fidelity (or infidelity) within relationships has
been extensively studied in social sciences. According to
studies conducted in Europe, Canada and the United
States, near one third of men and one fifth of women
have had relations outside of the couple [35]. Infidelity is
found in all social classes in all countries, including the
most repressive [35]. Despite these results, this wide-
spread perception in patients was an obstacle to applying
the recent French recommendations concerning HIV
screening.
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patients over the age of 70, considering their sexuality as
virtually non-existent or even disturbing. Although old
age is associated with a decrease in desire and impulsiv-
ity, and sometimes with pain during the act [36], the
sexuality of seniors is much more common than per-
ceived in our sample. Sexual activity persisted into old
age, sometimes with multiple partners [37]. In a study
conducted in 1998 among a 80-102-year-old group, in
residential retirement facilities, some had more than one
partner [38]. Moreover, sex tourism of the elderly is also
a factor in the transmission of sexual infections, for both
men and women [39]. In 2003 and early 2004, the distri-
bution of new cases of HIV and AIDS diagnosed in
France, presented a rise over the age of 54, especially
among men. From 2003 to 2006, nearly one out of six of
all positive screening tests recorded were men over the
age of 50 [40]. More recently, it has been estimated that
by 2015, more than half of the patients seropositive for
HIV in the United States would be more than 50 [41];
this population should be a new target of HIV screening
[42]. Thus, even if age-related physiological changes can
alter sexuality, the risk of infection by the AIDS virus
remains well and truly real and should not be ignored by
patients.
Some participants reported a religiosity that could be
another barrier to systematic HIV screening. Catholicism
is the most prevalent religion in France [43] and the
Catholic Church promotes premarital chastity and is
opposed to condom use [44] even if this is a more reli-
able method. Programs which only promote sexual ab-
stinence are not effective in reducing the risk of HIV
transmission [45-47]. Interviewed patients did not dwell
on these controversies but mentioned that the Catholic
religion could protect them against HIV if its rules were
fully respected. This feeling of protection provided by re-
ligion could be another obstacle to screening acceptance.
Limitation of the study
Our study took place in Yvelines, which is one of the
most prosperous areas in France thus the patients we
interviewed were not representative of the French popu-
lation. However, the aim of this qualitative study was to
get a better insight of the barriers coming from patients
themselves towards the untargeted HIV screening, while
avoiding potential subjective bias of the researchers. On
the basis of our results, further quantitative studies can
now be considered to quantify and rank the different
factors according to their importance.
Conclusion and recommendations
Systematic HIV screening in low-risk population is cur-
rently recommended by the French Health Authority
[21] according to a favorable cost/effective ratio inrecent studies [14]. Even if relevance of this screening is
still debated [8,48], it seemed important to focus on the
patients’ view, beyond the medico-economic consider-
ations. Further HIV information campaigns could focus
on the less frequent transmission modes in order to
improve the general public awareness and change its
perception about HIV mass screening. Talking about
sexuality should be less taboo in the patient-doctor rela-
tionship and religious feeling could be more considered
by practitioners when discussing with patients about
HIV screening.
HIV mass screening implementation could reduce the
number of new cases of HIV contamination and we think
our results could facilitate patient-physician discussion
regarding this screening.
Box 1: Summary of the barriers to HIV mass screening
HIV transmission was only associated with sexual
relations
HIV screening inevitably questioned spouse’s fidelity
Religion (Catholicism) was supposed to protect patients
from high-risk relations
Sexuality was supposed virtually inexistent among the
elderly
Cost in Public Health
Lack of information about screening methods
Fear of HIV / fear of the result
Feeling of being personally protected, specially by living
in FranceAppendix 1: Interview grid
1) The first for a “populational” angle, that of public
health. The issue will be presented with the
question: “There are new recommendations to
screen the whole general population for HIV,
from the age of 15 to 70. Do you think the whole
French population should be screened for HIV?”.
This will generate a consideration of the advantages
and disadvantages of a health policy.
2) The second for a more “personal” angle:
“Have you ever been screened for HIV?”, to take
stock.
●● If the answer is “yes”:
 was this following a high-risk situation?– “yes”→would you be screened outside of a
high-risk situation?
– “no”→what were your reasons?
 was it to know your status?
– “yes”→what were your reasons?
– “no”→ under what circumstances?
●●If the answer is “no”:
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situation?
– “yes”: for what reasons?
– “no”: for what reasons?
 would you get screened outside of a high-risk
situation?
– “yes”: for what purposes?
– “no”: for what purposes?3) The third, after information on the subject:
 Among the 150,000 people infected with HIV in
France, 1/3 or 50,000 are unaware. According to
you, what are the reason(s) for this figure?
 On a personal level, knowing these figures,
would you get screened outside of a high-risk
situation?
– “yes”: why?
– “no”: why?Competing interest
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